Precigen Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$3.19

+0.06 (+1.92%)

As of Mar 25, 1:46 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 78%

Hold 2 22%

Sell 0 0%

Price Target

Analyst Price Target +2,174.9% upside

Low Target $43.64

Average Target $72.57

High Target $99.14

Current Price $3.19

Current
$3.19

Target
$72.57

$43.64 $72.57 avg $99.14

Scenario Analysis

Bear Case

$43.64

1,268.0%

Low target

Base Case

$72.57

+2,174.9%

Avg target

Bull Case

$99.14

+3,007.8%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$5.47

-41.6% from high

52-Week Low

$1.11

+187.4% from low

Target vs 52W High

$72.57

+1,227.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%